Bharat Biotech Completes Recruitment of 13,000 Volunteers for Phase III Trials of Covaxin in Top Business News- News18.com published on December 22, 2020 leave a reply According to the company, the vaccine is developed and manufactured at Bharat Biotech's BSL-3, biocontainment facility. from Top Business News- News18.com https://ift.tt/2WBIzJV Tweet Share Share Share Share Previous Post Britain Tells Shoppers Food Is Plentiful Despite Freight Halt Next Post UK Economy Saw Partial Recovery In Q3, Recession Risks Ahead post written by: Rohit Related PostsSBI Raises $1.25 Billion Through Bonds from Overseas MarketThe successful issuance demonstrates the strong niche investor base SBI has created for itself in offshore capital markets, allowing it to efficiently raise fun… Continue ReadingFiscal Math to Worsen as Package to Placate Furious Farmers Inches Closer to RealityWe have missed the fiscal deficit target for two years and are likely to miss it again this year, say analysts, unless the government resorts to canny accountin… Continue ReadingSebi Nixes L&T Proposal for Rs 9,000 Crore Share BuybackL&T had proposed to buy back up to 6.1 crore shares from shareholders at a price of Rs 1,475 per equity share, aggregating to Rs 9,000 crore. The offer was … Continue ReadingLupin, Sun Pharma, Glenmark Recall Various Drugs from USThe ongoing voluntary nationwide recall has been classified as Class-I. Such recalls are for dangerous or defective products that predictably could cause seriou… Continue ReadingFPI Outflow Crosses Rs 4,000 Crore in January So FarAccording to data available with the depositories, FPIs withdrew a net amount of Rs 3,987 crore from equities and a net sum of Rs 53 crore from the debt market,… Continue Reading
0 comments: